Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inhibitor Therapeutics, Inc. (CBTE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inhibitor Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1042418.
Total stock buying since 2014: $195,192,002,245.
Total stock sales since 2014: $27,000.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 13,500 | $945 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 100,000 | $27,000 | 0 | $0 |
| 2017 | 1,200,000 | $195,192,000,000 | 2,500,000 | $0 | 24,291,738 | $0 |
| 2016 | 0 | $0 | 10,240,000 | $0 | 0 | $0 |
| 2015 | 20,000,000 | $0 | 20,000,000 | $0 | 0 | $0 |
| 2014 | 10,000 | $1,300 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-12 | 13,500 | $945 | 0 | $0 | 0 | $0 |
| 2018-08 | 0 | $0 | 100,000 | $27,000 | 0 | $0 |
| 2017-12 | 1,200,000 | $195,192,000,000 | 0 | $0 | 0 | $0 |
| 2017-06 | 0 | $0 | 2,500,000 | $0 | 0 | $0 |
| 2017-03 | 0 | $0 | 0 | $0 | 24,291,738 | $0 |
| 2016-06 | 0 | $0 | 10,240,000 | $0 | 0 | $0 |
| 2015-09 | 20,000,000 | $0 | 20,000,000 | $0 | 0 | $0 |
| 2014-09 | 10,000 | $1,300 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-02 | Hasara Garrison J. (CFO and Treasurer) | Buy | 13,500 | .07 | 945 |
| 2018-08-30 | Hasara Garrison J. (CFO and Treasurer) | Sale | 100,000 | .27 | 27,000 |
| 2017-12-19 | Cross Stefan | Buy | 600,000 | 162,660.00 | 97,596,000,000 |
| 2017-12-19 | Mayne Pharma Group Ltd | Buy | 600,000 | 162,660.00 | 97,596,000,000 |
| 2017-06-30 | Hedgepath, Llc (10% Owner) | Sale | 2,500,000 | .00 | 0 |
| 2017-03-08 | Watson W. Mark (Director) | Option Ex | 900,000 | .00 | 0 |
| 2017-03-08 | Cross Stefan (Director) | Option Ex | 600,000 | .00 | 0 |
| 2017-03-08 | Ono Richard Dana (Director) | Option Ex | 750,000 | .00 | 0 |
| 2017-03-08 | Hasara Garrison J. (CFO and Treasurer) | Option Ex | 7,000,000 | .00 | 0 |
| 2017-03-08 | Virca Nicholas J (President and CEO) | Option Ex | 15,041,738 | .00 | 0 |
| 2016-06-15 | Hedgepath, Llc (10% Owner) | Sale | 5,120,000 | .00 | 0 |
| 2016-06-15 | Odonnell Francis E Jr (Executive Chairman) | Sale | 2,560,000 | .00 | 0 |
| 2015-09-10 | Hedgepath, Llc (10% Owner) | Sale | 20,000,000 | .00 | 0 |
| 2015-09-10 | Odonnell Francis E Jr (Executive Chairman) | Buy | 20,000,000 | .00 | 0 |
| 2014-09-08 | Watson W. Mark (Director) | Buy | 10,000 | .13 | 1,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of CBTE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inhibitor Therapeutics, Inc. (symbol CBTE, CIK number 1042418) see the Securities and Exchange Commission (SEC) website.